# Exploring the Impact of Gender and Age of Onset on Psoriasis Treatment Management

**Authors:** Tair Lax, Edia Stemmer, Noga Fallach, Guy Shrem, Michal Schreiber-Divon, Snait Ayalon, Eitan Giat, Inbal Mor, Mali Salmon-Divon

PMC · DOI: 10.3390/jcm14124090 · Journal of Clinical Medicine · 2025-06-10

## TL;DR

This study shows that men with early-onset psoriasis receive stronger treatments earlier than women, suggesting treatment strategies should consider gender and age of onset.

## Contribution

The study reveals gender-specific treatment patterns in psoriasis that vary by disease onset, emphasizing the need for personalized management.

## Key findings

- Men with early-onset psoriasis were more likely to receive systemic and biological therapies than women.
- Early-onset patients, regardless of gender, started phototherapy earlier than late-onset patients.
- No significant gender-based treatment differences were found in late-onset psoriasis cases.

## Abstract

Background: Psoriasis is a chronic inflammatory skin disease characterized by a bimodal onset distribution, with cases categorized as early-onset or late-onset. While the prevalence of psoriasis is nearly equal between genders, men typically experience more severe forms of the disease, leading to differences in treatment approaches and clinical outcomes. The aim of this study was to investigate gender-based differences in treatment patterns among psoriasis patients, with a focus on how these differences vary by disease onset (early vs. late). Methods: A retrospective cohort study including individuals diagnosed with psoriasis between 1998 and 2022 through Clalit Health Services (CHS) in Israel. Gender-based differences in treatment patterns by psoriasis onset were analyzed using Chi-square and Fisher exact tests and survival analyses. Results: The disease onset showed a bimodal distribution among 3999 individuals, with women experiencing earlier onset compared to men (median age 37.2 vs. 40.1 years; p < 0.001). In early-onset psoriasis, men were significantly more likely than women to receive systemic (17.9% vs. 6.5%; p < 0.001) and biological therapies (3.8% vs. 1.6%; p = 0.005) and initiated these treatments earlier (p < 0.001). In contrast, no significant gender-based treatment differences were observed in late-onset cases. Regardless of gender, early-onset patients began phototherapy earlier than late-onset patients (p < 0.001). Conclusions: Our results suggest that disease onset timing may influence treatment decisions and highlight the need for a more personalized approach to psoriasis management that considers both gender and age of onset.

## Linked entities

- **Diseases:** psoriasis (MONDO:0005083)

## Full-text entities

- **Diseases:** skin disease (MESH:D012871), inflammatory (MESH:D007249), Psoriasis (MESH:D011565)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12193760/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12193760/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12193760/full.md

---
Source: https://tomesphere.com/paper/PMC12193760